Table 1.
Association of COMMD4 TMA scores with clinicopathological features.
Characteristic | Total, n | Nuclear intensity low < = median, n | Nuclear intensity high > median, n | Nuclear intensity Chi p-value | Cytoplasmic intensity low < = Median, n | Cytoplasmic intensity high > median, n | Cytoplasmic intensity Chi p-value |
---|---|---|---|---|---|---|---|
Histological type | |||||||
ADC | 74 | 54 | 20 | 0.0032 | 33 | 41 | 7.51 × 10−9 |
SCC | 78 | 72 | 6 | 70 | 8 | ||
Age | |||||||
Age < = 65 | 109 | 89 | 20 | 0.6825 | 77 | 32 | 0.3094 |
Age >65 | 43 | 37 | 6 | 26 | 17 | ||
Sex | |||||||
Male | 113 | 101 | 12 | 0.0005 | 88 | 25 | 2.71 × 10−5 |
Female | 38 | 24 | 14 | 15 | 23 | ||
Tumour grade | |||||||
Grade 1 | 11 | 10 | 1 | 0.1700 | 9 | 2 | 0.4978 |
Grade 2 | 58 | 51 | 7 | 39 | 19 | ||
Grade 3 | 72 | 55 | 17 | 46 | 26 | ||
Surgical stage | |||||||
Stage IA–IB | 54 | 45 | 9 | 0.8147 | 42 | 12 | 0.1202 |
Stage IIA–IIB | 61 | 49 | 12 | 38 | 23 | ||
Stage IIIA–IIIB | 34 | 29 | 5 | 21 | 14 | ||
TNM score | |||||||
TNM - T (1–2) | 119 | 97 | 22 | 0.5498 | 84 | 35 | 0.2283 |
TNM - T (3–4) | 33 | 29 | 4 | 19 | 14 | ||
TNM - N 0 | 67 | 55 | 12 | 0.9857 | 50 | 17 | 0.0880 |
TNM - N 1 | 65 | 54 | 11 | 38 | 27 | ||
TNM - N 2 | 18 | 15 | 3 | 14 | 4 |
ADC adenocarcinoma, SCC squamous cell carcinoma, TNM tumour, node, metastasis.